Focus on Healthcare and Biotechnology Investor Relations
Healthcare and biotechnology are important areas of specialization for MBS, and with almost three decades of experience in these sectors, we offer our clients the expert knowledge base to effectively engage with the investment community.
Within our healthcare and biotech practice group, a standout area of success has been our ability to attract new and influential investment community relationships for clients, backed by compelling and strategic investor communications. As a result of our industry focus, we have established long-standing relationships with the key players in the healthcare and biotech industries, and have dedicated resources in place for the marketing of our healthcare clients.
We have worked with companies in medical devices, biotechnology, healthcare technology, healthcare distribution, specialty pharmaceuticals and managed care, from pre-IPO situations to mid-cap companies.
With backgrounds spanning portfolio management, sell side research and equity capital markets, MBS’s healthcare practice group has the necessary technical, regulatory and financial knowledge to provide effective IR counsel to its healthcare and biotechnology client base.